Inactive Instrument
Aradigm Corporation Share Price Nasdaq
Stocks
US0385054004
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 48.85L 42.87L 39.92L 36.72L 68.83L 47Cr 70.02L 4.74Cr 1.85Cr 23Cr 1.83Cr 1.79Cr 80Cr | P/E 2016 |
-0.72x | P/E 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.28Cr 1.12Cr 1.05Cr 96.2L 1.8Cr 122.27Cr 1.83Cr 12Cr 4.86Cr 61Cr 4.8Cr 4.7Cr 209.5Cr | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +36.88% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +36.88% | +25.50% | - | - | 7L | |
| +0.32% | +5.07% | -2.86% | +11.56% | 4.79TCr | |
| -2.24% | +0.31% | +393.45% | +615.13% | 3.91TCr | |
| +1.40% | +3.69% | +12.21% | +46.79% | 3.67TCr | |
| +13.94% | +20.49% | +22.85% | +7.42% | 4.05TCr | |
| -0.73% | +3.38% | +4.94% | +41.45% | 2.8TCr | |
| +0.40% | -0.30% | - | - | 1.68TCr | |
| -3.12% | +7.39% | +26.03% | +124.08% | 1.59TCr | |
| -1.23% | -4.11% | +1.77% | +8.15% | 1.36TCr | |
| +6.79% | +8.17% | -4.97% | -28.52% | 1.38TCr | |
| Average | +5.24% | +4.64% | +56.68% | +103.26% | 2.8TCr | |
| Weighted average by Cap. | +2.21% | +5.03% | +72.71% | +125.13% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 2L 2L 2L 1L 3L 1.86Cr 3L 18.91L 7L 92.39L 7L 7L 3.19Cr | 1.45Cr 1.27Cr 1.18Cr 1.09Cr 2.04Cr 138.19Cr 2.07Cr 14Cr 5.49Cr 69Cr 5.43Cr 5.31Cr 236.79Cr |
| Net income | -3.29Cr -2.89Cr -2.69Cr -2.48Cr -4.64Cr -314.68Cr -4.72Cr -32Cr -12Cr -156.06Cr -12Cr -12Cr -539.19Cr | -1.07Cr -93.95L -87.48L -80.47L -1.51Cr -102.27Cr -1.53Cr -10Cr -4.06Cr -51Cr -4.02Cr -3.93Cr -175.24Cr |
| Net Debt | -93.72L -82.25L -76.59L -70.45L -1.32Cr -90Cr -1.34Cr -9.09Cr -3.56Cr -44Cr -3.52Cr -3.44Cr -153.42Cr | 79.13L 69.44L 64.67L 59.48L 1.11Cr 76Cr 1.13Cr 7.67Cr 3Cr 37Cr 2.97Cr 2.91Cr 129.53Cr |
Employees
-
